Template:Cefuroxime: Difference between revisions

Jump to navigation Jump to search
(Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100%; background:#F8F8...")
 
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 2: Line 2:
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Cefuroxime|{{fontcolor|#6C7B8B|Cefuroxime}}]]'''''
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Cefuroxime|{{fontcolor|#6C7B8B|Cefuroxime}}]]'''''
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left |CEFUROXIME<sup>®</sup>,ZINACEF<sup>®</sup>,KEFUROX<sup>®</sup> FDA Package Insert
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left |ZINACEF<sup>®</sup>,CEFUROXIME<sup>®</sup> FDA Package Insert
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime description|Description]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime description|Description]]
Line 23: Line 23:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime how supplied|How Supplied]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime how supplied|How Supplied]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime compatibility and stability |Compatibility and Stability ]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime direction for use|Direction For Use]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime labels and packages|Labels and Packages]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime labels and packages|Labels and Packages]]
|-
|-
|}
|}

Latest revision as of 03:05, 6 January 2014